SHINMURA, T.; ADACHI, K.; YAMAGUCHI, Y.; IZAWA, S.; HIJIKATA, Y.; EBI, M.; FUNAKI, Y.; OGASAWARA, N.; SASAKI, M.; KASUGAI, K. Vonoprazan-Based Triple-Therapy Could Improve Efficacy of the Tailored Therapy of Helicobacter pylori Infection. Journal of Gastrointestinal and Liver Diseases, v. 28, n. 4, p. 389-395, 9 dez. 2019.